CHMFL-BMX-078
|
C651278-10mg
|
≥98% |
1808288-51-8 |
10mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
CHMFL-BMX-078
|
C651278-100mg
|
≥98% |
1808288-51-8 |
100mg
|
¥ 18000.9
|
期货,请咨询 |
阿拉丁 |
CaMKII-IN-1
|
C651257-5mg
|
≥98% |
1208123-85-6 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
CaMKII-IN-1
|
C651257-50mg
|
≥98% |
1208123-85-6 |
50mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
CaMKII-IN-1
|
C651257-25mg
|
≥98% |
1208123-85-6 |
25mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
CaMKII-IN-1
|
C651257-10mg
|
≥98% |
1208123-85-6 |
10mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
CaMKII-IN-1
|
C651257-100mg
|
≥98% |
1208123-85-6 |
100mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
CARM1-IN-1
|
C651239-5mg
|
≥95% |
1020399-49-8 |
5mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
CARM1-IN-1
|
C651239-50mg
|
≥95% |
1020399-49-8 |
50mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
CARM1-IN-1
|
C651239-2mg
|
≥95% |
1020399-49-8 |
2mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
CARM1-IN-1
|
C651239-10mg
|
≥95% |
1020399-49-8 |
10mg
|
¥ 3100.9
|
期货,请咨询 |
阿拉丁 |
CYM50179
|
C651232-5mg
|
≥95% |
1355026-47-9 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
CYM50179
|
C651232-50mg
|
≥95% |
1355026-47-9 |
50mg
|
¥ 6200.9
|
期货,请咨询 |
阿拉丁 |
CYM50179
|
C651232-25mg
|
≥95% |
1355026-47-9 |
25mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
CYM50179
|
C651232-10mg
|
≥95% |
1355026-47-9 |
10mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
CYM50179
|
C651232-100mg
|
≥95% |
1355026-47-9 |
100mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
CAY10746
|
C651177-5mg
|
≥99% |
2247240-76-0 |
5mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
CAY10746
|
C651177-25mg
|
≥99% |
2247240-76-0 |
25mg
|
¥ 14000.9
|
期货,请咨询 |
阿拉丁 |
CAY10746
|
C651177-1mg
|
≥99% |
2247240-76-0 |
1mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
CAY10746
|
C651177-10mg
|
≥99% |
2247240-76-0 |
10mg
|
¥ 8800.9
|
期货,请咨询 |
阿拉丁 |
Cyclo(Arg-Gly-Asp-D-Phe-Cys)
|
C651166-5mg
|
≥97% |
862772-11-0 |
5mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
Cyclo(Arg-Gly-Asp-D-Phe-Cys)
|
C651166-1mg
|
≥97% |
862772-11-0 |
1mg
|
¥ 700.9
|
期货,请咨询 |
阿拉丁 |
Cyclo(Arg-Gly-Asp-D-Phe-Cys)
|
C651166-10mg
|
≥97% |
862772-11-0 |
10mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
Citalopram-d4hydrobromide
|
C651156-1mg
|
|
1219803-58-3 |
1mg
|
¥ 7300.9
|
期货,请咨询 |
阿拉丁 |